The forkhead box (Fox) superfamily of transcription factors has essential roles in organogenesis and tissue differentiation. Foxa1 and Foxa2 are expressed during prostate budding and ductal morphogenesis, whereas Foxa1 expression is retained in adult prostate epithelium. Previous characterization of prostatic tissue rescued from embryonic Foxa1 knockout mice revealed Foxa1 to be essential for ductal morphogenesis and epithelial maturation. However, it is unknown whether Foxa1 is required to maintain the differentiated status in adult prostate epithelium. Here, we employed the PBCre4 transgenic system and determined the impact of prostate-specific Foxa1 deletion in adult murine epithelium. PBCre4/Foxa1 loxp/loxp mouse prostates showed progressive florid hyperplasia with extensive cribriform patterning, with the anterior prostate being most affected. Immunohistochemistry studies show mosaic Foxa1 KO consistent with PBCre4 activity, with Foxa1 KO epithelial cells specifically exhibiting altered cell morphology, increased proliferation, and elevated expression of basal cell markers. Castration studies showed that, while PBCre4/Foxa1 loxp/loxp prostates did not exhibit altered sensitivity in response to hormone ablation compared with control prostates, the number of Foxa1-positive cells in mosaic Foxa1 KO prostates was significantly reduced compared with Foxa1-negative cells following castration. Unexpectedly, gene expression profile analyses revealed that Foxa1 deletion caused abnormal expression of seminal vesicle-associated genes in KO prostates. In summary, these results indicate Foxa1 expression is required for the maintenance of prostatic cellular differentiation.
The Forkhead Box (Fox in mice, FOX in human) family of transcription factors consists of 43 proteins, which are organized into 19 subfamilies based on amino-acid sequence conservation. 1 Foxa1 (originally termed hepatocyte nuclear factor one alpha; HNF1a) was originally discovered in mammals as a transcription factor in the liver. 2 Importantly, the structure of the DNA-binding domain of Foxa proteins contains a variant of the helix-loop-helix motif, giving it the appearance of a 'winged helix.' This structure closely resembles that of a linker histone 3 and enables Foxa1 to directly influence chromatin structure. In addition, the C terminus of Foxa1 binds to core histones and is required for chromatin opening in vitro. 4 For these reasons, Foxa proteins make DNA sequences accessible for the binding of additional transcriptional activators and/or repressors, and have accordingly been described as 'pioneer factors. ' The 'pioneering' function of Foxa proteins has led to the suggestion that these proteins enable cells to respond quickly to changes in their environment by altering transcriptional regulation of genes. The ability of Foxa transcription factors to impart 'competence' for the rapid initiation of gene expression has been suggested as central to their function. In addition, the observation that Fox family members are retained on mitotic chromosomes, 5, 6 suggests an important role for Foxa1 in the maintenance of cell fate.
Foxa1 and Foxa2 expressions are restricted to the epithelial compartment during embryonic prostate development. 7 Whereas Foxa2 expression is extinguished following budding morphogenesis, Foxa1 expression is maintained in the adult prostate epithelium. Our laboratory previously showed that Foxa1 expression is required for normal prostate organogenesis. 8, 9 In fact, the expression of Foxa proteins have an essential role during the development of several organs, and Foxa1 and Foxa2 have been shown to act in a cooperative manner during the normal development of the liver, lungs, dopaminergic neurons, and pancreas. 10 Our laboratory was the first to report the direct physical interaction of Foxa1 with the androgen receptor (AR) and the importance of Foxa1 expression for the regulation of prostate-specific gene expression. 11 While altered levels of Foxa1 and Foxa2 expression have been implicated in prostate cancer, [12] [13] [14] [15] [16] [17] the importance of Foxa1 expression in the adult, non-neoplastic prostate is unknown. Therefore, we undertook this study to determine the impact of prostate-specific genetic ablation of Foxa1 in adult mice.
MATERIALS AND METHODS Mouse Lines and Breeding

Foxa1
loxp mice have been previously described. 18 PBCre4 19 activity was detected 14 days after birth and increases with rising testicular androgen production and the onset of sexual maturity in mice. PBCre4 has been previously reported to result in prostate-specific Cre recombinase activity, and Gt(ROSA)26Sor tm4(ACTB-tdTomato,-EGFP)Luo /J mice (Jackson Laboratories, Bar Harbor, MA) express red fluorescence before, and green fluorescence following Cre-mediated recombination. 20 To identify specific cell populations targeted by Cre-mediated recombination in the PBCre4 mouse line, PBCre4 mice were bred with Gt(ROSA)26Sor 
Immunohistochemistry and Immunofluorescence
Slides were deparaffinized, rehydrated through a series of graded alcohols, and washed in double deionized water for 5 min. Tissues were then placed in antigen unmasking solution (Vector Labs, Burlingame, CA), and antigen retrieval was performed by microwaving samples for 20 min at 30% power in a 900 W microwave oven. Slides were then cooled to room temperature, and then washed three times for 10 min in PBS (pH 7.4). For immunohistochemistry, all incubations were performed at room temperature unless otherwise stated. Endogenous peroxidase activity was blocked with the use of Peroxidase blocking reagent (Dako North America, Carpinteria, CA) for 20 min, after which sections were again washed in PBS three times for 10 min. Prepared slides were incubated in horse serum for 30 min to reduce non-specific antibody binding. Slides where then incubated overnight at 4 1C in a humidified chamber with the primary antibody. After three 10-min washes in PBS, slides were then incubated overnight in the presence of primary antibody. On the following day, slides were then washed three times for 10 min with PBS and biotinylated secondary antibody diluted in PBS was then added. Primary antibody was visualized using the Vectastain Elite ABC Peroxidase kit (Vector Labs) according to the manufacturer's protocol with DAB in substrate buffer as chromogen (Thermo Scientific, Fremont, CA). For immunofluorescence studies, the above procedure was followed up until the peroxidase blocking step, at which point blocking was done for an hour in 12.5% bovine serum albumin (BSA) in PBS. Primary antibodies were incubated overnight in 12.5% BSA in PBS, and the next day, after washing in PBS, slides were incubated for 1 hr in the dark with Alexa Fluor (Molecular Probes, Life Technologies, Grand Island, NY) secondary antibodies (1:100 in blocking solution). Following PBS wash, slides were mounted in DAPI-cotaining Vector medium. Primary antibodies used included Krt 8/18 (Fitzgerald), Krt 14 (Dako), Foxa1, AR, GFP, p63 (Santa Cruz), 8, 21, 22 and Foxc1 (Sigma; http://www.proteinatlas.org/). Ki67 staining was performed by the Vanderbilt Experimental Pathology Core, as previously reported. 8 Slides were visualized on a Zeiss Axio Imager.M1 microscope with Axiovision image capture software (Carl Zeiss Microimaging, Thornwood, NY).
Quantitative RT-PCR RNA was extracted using the RNeasy kit from Qiagen (Valencia, CA, USA). Reverse transcription was conducted using SuperScriptII from Invitrogen (Carlsbad, CA, USA). Real-time PCR was performed on iCycler using iQ SYBR Green Supermix from Bio-Rad (Hercules, CA, USA). PCR was performed as follows: 95 1C for 4 min, followed by 40 cycles of 95 1C/30 s, 58 1C/30 s, and 72 1C/30 s. All samples were normalized to GAPDH. Results were expressed as fold change of each sample versus control using the 2 ( À DDCt) method. 23 Primer sequences used in this study are as follows: Foxc1
Transient Transfection and Coimmunoprecipitation
Coimmunoprecipitation of both endogenously expressed Foxc1 and transiently overexpressed Foxc1 with AR was 
Microarray Analysis
Microarray analysis on RNA extracted from anterior prostates (AP) dissected from control and experimental mice, as well as the seminal vesicles dissected from control mice, was performed using the GeneTitan1.1.ST mouse array (Affymetrix Corp; Santa Clara, CA) by the Vanderbilt Technologies for Advanced Genomics (VANTAGE) core. The GeneTitan1.1.ST mouse array chip contains probes for 26 166 coding transcripts (RefSeq), and B7000 non-coding transcripts, including 2000 long intergenic non-coding transcripts. Instrument control and data acquisition were performed using the Affymetrix GeneChip Command Console. Fold change was calculated in a log base 2 space, using the following formula (Fold Change ¼ 2 (experimental À control) ), followed by inverting and negating ratios less than 1. Microarray analysis was performed both to identify increases in seminal vesicle-associated gene expression in the AP of Foxa1 KO mice and to identify genes whose expression was altered coordinately following both castration and Foxa1 KO. See Supplementary Data for gene lists.
RESULTS
Foxa1 Expression is Restricted to Luminal Epithelium: a Subpopulation of Cells that are Efficiently Targeted by PBCre4
As FOXA1 expression in the human prostate is restricted to luminal epithelium, while basal prostate epithelium fails to exhibit positive FOXA1 immunostaining, 26 we performed dual immunofluorescence microscopy to determine the extent of Foxa1 colocalization with cytokeratin (Krt) 8/18 and Krt14, which are markers of luminal and basal epithelium, respectively ( Figure 1 ). We performed this staining on the anterior prostates (AP), as this lobe of the murine prostate has the largest population of Krt14-positive basal cells. As is the case in humans, 26 results show that Foxa1 expression is restricted to Krt 8/18-positive epithelium (Figure 1d , inset) in the adult mouse and is not detected in the Krt14-positive basal cell layer (Figure 1h , inset). Promoters vary in their penetrance, which is the primary determinant in their ability to efficiently drive transgene expression in specific cell types. Therefore, selecting the proper promoter to drive Cre recombinase is essential. Initial immunofluorescence studies required that we utilize a promoter specifically expressed in luminal epithelium to achieve genetic ablation of Foxa1 in the prostate. In order to verify the suitability of the PBCre4 transgenic line for the targeting of Foxa1-positive luminal prostate epithelium, we bred PBCre4 mice to the Gt(ROSA)26Sor
tm4 ( In summary, these data suggest PBCre4 is suitable to achieve conditional Foxa1 knockout in the murine prostatic luminal cells. loxp/loxp mice) showed changes as early as 7 weeks of age in the AP and DP, which progressed to florid hyperplasia complete with cribriform patterning (Figure 3 ; bottom panel). Progressive hyperplasia was present in all lobes by 24 weeks. We did not observe epithelial cell invasion into the prostatic stroma. In keeping with PBCre4/ Gt(ROSA)26Sor tm4(ACTB-tdTomato,-EGFP)Luo /J cre mapping studies, Foxa1 knockout was mosaic in nature in all lobes of the prostate (Figure 4a ; top left). Ki67 staining revealed a increase in the number of proliferating cells (Figure 4b ; top right), with the largest proportion of Ki67 staining present in the AP and DP. We previously reported that FOXA1 loss coincided with increased Ki67 staining in human bladder cancer specimens, suggesting that Foxa1-negative murine prostate epithelium would be Ki67 positive. 21 However, this did not appear to be the case, as increases in Ki67 labeling were not restricted to Foxa1-negative cells as shown by dual immunofluorescence of the AP dissected from 24 week-old PBCre4/Foxa1 loxp/loxp mice (Figure 4c ; bottom panel). These results indicate PBCre4-mediated Foxa1 knockout increases the proliferation of prostate epithelium in a manner that is not simply restricted to Foxa1 knockout epithelium.
PBCre4/Foxa1
loxp/loxp Mice Exhibit Altered Localization of p63-Positive Basal Cells Embryonic Foxa1 knockout was previously reported to result in an expansion of the basal cell population. 8 loxp/loxp mice showed prostatic atrophy after castration, as indicated by significant decreases in prostate weight (Figure 6a ; Student's t-test; Po0.0005), decreased Ki67 immuno positivity, as well as histological alterations (regression of glandular structure, increased expansion of smooth muscle, and altered nuclear to cytoplasmic ratio; data not shown). Comparison of tissue dissected from intact and castrated 33-week-old PBCre4/Foxa1 loxp/loxp mice revealed a significant decrease in the number of Foxa1-positive cells following castration. (Figure 6c ; Mann-Whitney test; P ¼ 0.0003). No significant changes in Foxa1 immunostaining were detected when comparing intact and castrated tissue dissected from 33-week-old Foxa1 loxp/loxp mice (Figure 6c ; Mann-Whitney test; P ¼ 0.7). These results potentially indicate that the subpopulation of prostate luminal epithelium not targeted by PBCre4, and therefore retain Foxa1, are especially sensitive to androgen deprivation, while the Foxa1-null cells are more resistant to castration.
PBCre4-Foxa1 KO Prostates Express Markers of Seminal Vesicle Differentiation
We performed microarray analysis to gain further insights into changes in gene expression following Foxa1 knockout. Microarray analysis on the Foxa1 KO AP dissected from a 33-week-old mouse, as well as age-matched controls, revealed that three of the six major seminal vesicle secretions (SVS) genes were upregulated in this lobe of the murine prostate. Therefore, microarray analysis was performed on the seminal vesicles, and a comparison of genes expressed in intact seminal vesicles was made to the Foxa1 KO AP. This analysis revealed that 57 genes normally specific to the seminal vesicles were now expressed by the Foxa1 KO AP (see Supplementary Data for gene list). Because Foxa1 activity is so (Figure 7a; ). In addition, we were able to detect significant increases in the expression of Fam3b, Trpv6, and Prom2, all of which are normally expressed in a relatively seminal vesicle-specific manner (Figure 7a ). Immunohistochemistry of murine seminal vesicle showed that Foxc1 is expressed at high levels in this androgen target tissue (Figure 7b; left panel) . Furthermore, while we failed to detect Foxc1 expression in AP prostates dissected from 40-week-old Foxa1 loxp/loxp (Figure 7b ; middle panel), we detected increased Foxc1 expression in AP epithelial cells dissected from age-matched PBCre4/Foxa1 loxp/loxp mice ( Figure 7b ; right panel). As we have previously shown that Foxa1 interacts with the AR in human prostate epithelial cells, we postulated that Foxc1 may also physically interact with AR in tissues where these transcription factors are coexpressed. To test this hypothesis, we performed coimmunoprecipitation experiments on cells expressing both AR and Impact of prostate-specific FOXA1 knockout DJ DeGraff et al Figure 3 Prostates dissected from PBCre4/Foxa1 loxp/loxp mice exhibit progressive hyperplasia with cribriform patterning. Anterior, dorsal, ventral, and lateral prostatic tissue dissected from 7-, 24-, and 33-week-old Foxa1 loxp/loxp control mice, which exhibit normal histomorphology following H&E stain (a). Conversely, H&E stain of anterior, dorsal, ventral, and lateral prostatic tissue dissected from age-matched PBCre4/Foxa1 loxp/loxp mice reveals largely progressive hyperplasia with extensive cribriform patterning (b). This phenotype was most pronounced in the anterior prostate.
Impact of prostate-specific FOXA1 knockout DJ DeGraff et al
Foxc1. The WPMY-AR cell line, which is a myofibroblastic cell line engineered to stably overexpress AR, 24 was chosen because Foxc1 expression was previously reported to be increased in prostatic stroma. 27 Immunoprecipitation of Foxc1, followed by western blotting analysis, showed that AR co-precipitated indicating a physical interaction with endogenously expressed Foxc1 in WPMY-AR cells (Figure 7c ). Our ability to detect this interaction was enhanced following overexpression of Foxc1 in WPMY-AR cells (Figure 7d ). These results indicate Foxc1 interacts with AR, and that this complex may be important in the regulation of AR target genes in Foxa1-negative cells.
DISCUSSION
We had previously reported an essential role for Foxa1 expression during normal prostate development, 8 where knockout of Foxa1 during embryonic development resulted in the failure of prostate morphogenesis, an expansion of a p63-positive basal cell population, and the retention of embryonic markers of prostate development, including Foxa2. However, embryonic knockout of Foxa1 made it impossible to determine the importance of this transcription factor for the maintenance of normal prostatic differentiation that occurs with sexual maturation. In the current study, we used the PBCre4 system to ablate Foxa1 in a prostate-specific manner during sexual maturation. We show that the PBCre4 efficiently targets the luminal prostate epithelium that expresses Foxa1 (see Figures 1 and 2 , as well as Supplementary Data), and that PBCre4-mediated Foxa1 knockout results in progressive and florid hyperplasia with cribriform patterning, which is most pronounced in the AP (see Figure 3 ). These studies revealed an important role for Foxa1 Impact of prostate-specific FOXA1 knockout DJ DeGraff et al expression in the adult prostate for the maintenance of a differentiated phenotype. PBCre4 targets luminal prostate epithelium, resulting in a 'mosaic' knockout of Foxa1. This phenomenon revealed differences in the relative androgen sensitivity of Foxa1-positive and -negative cells. These results indicate that Foxa1-positive cells are more sensitive to castration (or that Foxa1 negative cells are more resistant to castration), enabling a relative expansion of the Foxa1-negative epithelial cell population ( Figure 6 ). It is impossible to know whether these results are a direct influence of decreased AR action on the epithelial cell compartment (which is now heterogenous in regard to Foxa1 expression) or whether they are a reflection of differences in which FOXA1-positive and -negative epithelium responds to androgen-regulated paracrine signals from the stroma. 28 Put differently, in the epithelium our observation may be the result of the physical interaction between Foxa1 and AR, as well as the fact that these transcription factors act in a cooperative manner to regulate gene expression in response to paracrine stromal signals.
Further studies are planned to identify the exact mechanism by which Foxa1 status influences sensitivity to androgens. It is also interesting to note that PBCre4 induced recombination in the majority of prostate epithelium as revealed by our reporter mouse studies (see Figure 2 and Supplementary Data), which would predict a more complete knockout of Foxa1 then was revealed in our studies (see Figure 4 ). This apparent discrepancy may indicate that Foxa1 knockout is initially toxic in a subset of prostate epithelium, while additional populations in which Foxa1 is successfully ablated survive this genetic change. Nonetheless, Foxa1 ablation with the PBCre4 did result in a striking phenotype (see Figure 3) . Further study is required to determine the short-term impact of Foxa1 knockout.
AR expression is widely distributed among tissues derived from the developing germ layers (endoderm, ectoderm, and mesoderm); yet, precise genes associated with differentiation are regulated by AR in specific cell populations. 29 The cell-specific expression of AR target genes is explained via the combinational control of gene expression model. This Impact of prostate-specific FOXA1 knockout DJ DeGraff et al paradigm predicts that the presence and activity of a unique combination of different regulatory proteins during development and in adult tissues dictates cell fate. 29, 30 The family of forkhead proteins is particularly interesting as their expression is temporally restricted during development and specific to adult cell populations. We reported that the AR and Foxa1 protein formed a complex via their DNA-binding domains on multiple prostate specific genes and that this complex is critical for differentiation of the prostate gland. 8, 9, 11 It is now widely recognized that the AR/FOXA1 complex is fundamental in androgen action in the prostate, and the function of FOXA1 has been extended to include Figure 6 For caption see page 735.
Impact of prostate-specific FOXA1 knockout DJ DeGraff et al Impact of prostate-specific FOXA1 knockout DJ DeGraff et al estrogen receptor action in human breast. 31 Recently, ChIP-Seq experiments on the glucocorticoid receptor showed that binding sites for this steroid receptor were enriched for forkhead binding sites, but the precise forkhead remains unidentified. 32 Here we report that the conditional knockout of Foxa1 in the adult mouse prostate results in the loss of prostate-specific gene expression and the gain of at least 57 genes normally expressed in the seminal vesicle. Within this group of genes, we see expression of the androgen-regulated seminal vesicle secretion (SVS) genes. SVS2 is expressed in both the prostate and seminal vesicles, 33, 34 but SVSI and SVS3, SVS4, SVS5, and SVS6 are major androgen-regulated secretory proteins specific to the seminal vesicles. 35 In keeping with this observation, we discovered that Foxa1 KO resulted in the increased expression of Nr4a3 and Foxc1 (see Supplementary Data), both of which are associated with mesodermal development. 36, 37 This switch of gene expression demonstrates that the prostate, which originates from endoderm, can be reprogrammed by the loss of Foxa1 to express androgen target genes that are specific to the seminal vesicle, which originates from mesoderm. This reprogramming is consistent with other studies that have demonstrated that not all AR-binding sites depend upon FOXA1 binding, and, in fact, loss of FOXA1 can reprogram AR to bind alternative promoters and result in the expression of AR-regulated genes that are normally repressed in the presence of FOXA1. 38 In the mouse prostate, loss of FOXA1 appears to mediate the expression of seminal vesicle genes. In order to determine possible alternative forkhead-binding partners for AR, we looked both in our microarray analysis of the PB-Foxa1 mouse and the literature. Foxc1 was the most upregulated forkhead family member by microarray analysis, and analysis of Fox family members in prostate cancer cell lines had previously revealed that FOXA1 and FOXC1 were inversely expressed in androgen-dependent and independent cell lines. 27 Although Foxa1 expression is largely restricted to endoderm, Foxa1 is detected in some mesodermally and ectodermally derived tissues. 39, 40 However, IHC staining of the seminal vesicle shows that the epithelial cells are Foxa1 negative but Foxc1 positive. Also, IHC staining of the prostate shows that the control prostates are Foxc1 negative but the conditional knockout of Foxa1 results in expression of Foxc1 in the prostate epithelium. Further, we demonstrate that the AR and Foxc1 can directly interact suggesting that an AR/Foxc1 complex is important in androgen action in the seminal vesicle. Unfortunately, no seminal vesicle cell lines have been developed that would allow us to confirm the AR/Foxc1 complex regulates seminal vesicle genes that are enriched following Foxa1 knockout. However, it is interesting to note that B40% of primary prostate tumors are FOXA1 negative, and these negative prostate tumors exhibit relatively indolent behavior. 41 It would be interesting to determine the extent to which FOXC1 and seminal vesicle-related genes are upregulated in this tumor cohort, as well as the ramifications of these potential gene expression changes, in regard to tumor biology.
Forkhead transcription factors are grouped into subfamilies (such as the Foxa subfamily) based on the extent of sequence conservation within the DNA-binding domain. Of the 43 forkhead proteins, Foxb1, Foxb2, and Foxc1 have the next most conserved DNA-binding motifs to Foxa1. 1 Taken together, this suggests a model where some of the organspecific target genes induced by the AR can, in part, be due to specific complexes between this receptor and a forkhead protein. Similarly, this model would apply to other steroid receptors that would partner with specific forkhead proteins to control steroid receptor action in multiple organs.
